{"symbol":"REGN","fiscalQuarter":"Q4-2008","reportDate":"2009-02-26","reportTime":"BMO","status":"reported","company":{"name":"Regeneron Pharmaceuticals, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/REGN/earnings/Q4-2008","postBrief":{"headline":"Regeneron Pharmaceuticals Misses on EPS \u2014 Stock Down 10.72%","keyNumbers":[{"metric":"EPS","actual":"$-0.40","expected":"N/A","surprise":"-34.68%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management expressed concerns about current market conditions impacting performance.","They highlighted ongoing challenges in the pharmaceutical landscape."],"summary":"Management's tone was defensive, reflecting the difficulties faced in the current market. They did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No guidance data was provided during the earnings call.","changes":[]},"whatItMeans":"Regeneron's earnings report indicates a challenging quarter, with the company missing EPS expectations. The stock reacted negatively, dropping 10.72%, likely due to investor concerns about the company's performance and lack of guidance. This could signal potential difficulties ahead as the company navigates a tough market environment.","metaDescription":"Regeneron Pharmaceuticals (REGN) Q4 2008 earnings: EPS missed. Stock down 10.72%. Full breakdown."}}